日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pomgulated methionil (LY2140023) in schizophrenia patients: a systematic review and meta-analysis

甲硫氨酸(LY2140023)在精神分裂症患者中的应用:系统评价和荟萃分析

Aboushawareb, Hala; Abbas, Omar F; Ghabour, Hend; Hassan, Omar; Shelbaya, Ali Nagy; Abdelsalam, Rahma; Meshref, Mostafa

Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry

托法替尼与肿瘤坏死因子抑制剂相比的疗效,以及托法替尼作为不同治疗方案在类风湿性关节炎患者中的疗效:来自美国CorEvitas类风湿性关节炎注册研究的结果

Harrold, Leslie R; Bingham, Clifton O; Pope, Janet E; O'Brien, Jacqueline; Moore, Page C; Roberts-Toler, Carla; Yu, Miao; Sweet, Lindsay L; Shelbaya, Ahmed; Masri, Karim R

Unilateral Upper Extremity Paralysis Secondary to Hypokalemia and Fasting: A Case Report

低钾血症和禁食引起的单侧上肢瘫痪:病例报告

Adler, Alexander; Shelbaya, Samy; McCormick, Sean

Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis

大规模蛋白质组学鉴定出主动脉瓣狭窄的新型生物标志物和循环风险因素

Shelbaya, Khaled; Arthur, Victoria; Yang, Yimin; Dorbala, Pranav; Buckley, Leo; Claggett, Brian; Skali, Hicham; Dufresne, Line; Yang, Ta-Yu; Engert, James C; Thanassoulis, George; Floyd, James; Austin, Thomas R; Bortnick, Anna; Kizer, Jorge; Freitas, Renata C C; Singh, Sasha A; Aikawa, Elena; Hoogeveen, Ron C; Ballantyne, Christie; Yu, Bing; Coresh, Josef; Blaha, Michael J; Matsushita, Kunihiro; Shah, Amil M

The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study

生物类似药使用对医疗保险肿瘤护理模式下总护理成本和医疗服务提供者财务绩效的影响:一项基于人群的模拟研究

Yang, Jingyan; Chaudhry, Basit I; Yue, Andrew T; Roth, Joshua A; Kelton, John M; Shelbaya, Ahmed; Tran, Lisa; Li, Meng

A descriptive analysis of real-world oncology biosimilar use in Japan

日本真实世界肿瘤生物类似药使用情况的描述性分析

Roth, Joshua A; Rahshenas, Makan; Nowacki, Grégoire; Masurkar, Nihar; Shelbaya, Ahmed; Tajima, Kentaro; Dorman, Stephanie; Ono, Chiho

Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study

社区老年人瓣膜性心脏病的分期:社区动脉粥样硬化风险研究

Shelbaya, Khaled; Claggett, Brian; Dorbala, Pranav; Skali, Hicham; Solomon, Scott D; Matsushita, Kunihiro; Konety, Suma; Mosley, Thomas H; Shah, Amil M

Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians

美国肿瘤单克隆抗体生物类似药的认知演变、应用及实际应用经验:来自支付方和医生的视角

Yang, Jingyan; Blinzler, Kelly; Lankin, Joshua; Vijayakumar, Sapna; Maculaitis, Martine C; Shelbaya, Ahmed

Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)

英夫利昔单抗-dyyb(英夫利昔单抗生物类似药)对临床和患者报告结局的影响:一项在美国和加拿大开展的炎症性肠病患者观察性真实世界研究的 1 年随访结果(ONWARD 研究)

Abraham, Bincy; Eksteen, Bertus; Nedd, Khan; Kale, Hrishikesh; Patel, Dipen; Stephens, Jennifer; Shelbaya, Ahmed; Chambers, Richard; Soonasra, Arif

Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives

生物类似药贝伐珠单抗能否为美国癌症患者提供经济实惠的治疗选择?来自美国商业保险和联邦医疗保险支付方的预算影响分析

Yang, Jingyan; Liu, Rongzhe; Ektare, Varun; Stephens, Jennifer; Shelbaya, Ahmed